共 961 条
[51]
da Silva MH(2008) extracts Curr Atheroscler Rep 10 386-430
[52]
Posadas SJ(2016)Oxidative stress and left ventricular remodelling after myocardial infarction Vasc Pharmacol 81 22-949
[53]
Caz V(2015)Experimental myocardium infarction in rats: analysis of the model Pharmacol Res 101 74-117
[54]
Largo C(2015)Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a veterans administration cooperative study BMC Cardiovasc Disord 15 95-1966
[55]
De la Gándara B(2014)Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The adverse experience committee; and the multicenter diltiazem Postinfarction research group Ren Fail 36 413-3552
[56]
Matallanas B(2018)Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-heart failure trial (V-HeFT) study group Hum Exp Toxicol 37 420-171
[57]
Reglero G(2007)Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group Food Chem 105 940-25
[58]
Kayashima T(2013)Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in congestive heart failure (PICO) trial J Kerbala Univ 11 109-463
[59]
Matsubara K(2014)Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators Chem Res Toxicol 27 1958-361
[60]
Sinkovic A(2002)A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone trial investigators J Agric Food Chem 50 3549-70